Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.
Mayers DL, Japour AJ, Arduino JM, Hammer SM, Reichman R, Wagner KF, Chung R, Lane J, Crumpacker CS, McLeod GX, et al.
Antimicrob Agents Chemother. 1994 Feb;38(2):307-14.PMID: 8192457 [PubMed - indexed for MEDLINE]Related articlesFree article